Samsara Vision's SING IMT: Game Changer for the Advanced AMD Patient

In this episode, I discuss Samsara Vision's SING IMT and its benefits of vision improvement for patients with AMD with Rebecca Kammer, OD, PhD.

Brought to you by Alcon

· Welcome to another exciting episode of Eye Care insider :14

· Intro for Rebecca Kammer, OD, PhD :27

· Dr. Kammer's background 1:28

· Defining late-stage AMD patients and treatments available 5:11

· The SING IMT 9:46

· US Concerto Study Website – to learn more about the study 13:13

· Visual acuity and the SING IMT 13:48

· US trial, recruitment and patient eligibility 17:18

· Contact toll-free 1-866-393-3767 discuss eligibility, participation and questions 20:39

· SING IMT as an option for patients 22:55

· Thanks for listening 27:30

We'd love to hear from you! Send your comments/questions to Dr. Mali at [e-mail]. Follow us on Twitter @Healio_OSN. You can reach Dr. Kammer at [e-mail].

Rebecca Kammer, OD, PhD, is the vice president of worldwide clinical and medical affairs for Samsara Vision, Inc., an adjunct professor at University of California, Irvine and a diplomate in low vision of the American Academy of Optometry.

Disclosures: Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; consultant/speaker for Genentech and Roche; equity owner for SNAPS; and grant/consultant for RetinAI. Kammer reports being a clinical advisor to Biovisics and Eyedaptic.